The influence of metabolic syndrome on the risk of hepatocellular carcinoma in patients with chronic hepatitis B infection in mainland China
Cancer Epidemiology, Biomarkers & Prevention Sep 27, 2019
Tan Y, Zhang X, Zhang W, et al. - Researchers evaluated 6,564 individuals with hepatitis B virus infection for the association between metabolic syndrome (MS), both in terms of its components and as a whole, and the risk of hepatocellular carcinoma (HCC). After a 45,668.0 person-year follow-up (76.0 ± 30.8 months), 89 incident HCC cases were identified. Increased HCC risk was evident in independent correlation with MS as a whole, central obesity, and type 2 diabetes among these patients from mainland China.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries